trending Market Intelligence /marketintelligence/en/news-insights/trending/Ed7bUTd8t3RPK2LJQ6ECTQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Illumina wins patent infringement suits against Premaitha, Ariosa in UK

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Illumina wins patent infringement suits against Premaitha, Ariosa in UK

Illumina Inc. said it won a favorable ruling in the patent infringement suits filed against Premaitha Health PLC and Ariosa Diagnostics Inc. in the U.K.

The High Court of Justice, Chancery Division, Patents Court in the U.K ruled that Premaitha's IONA test infringed patents related to the use of sequencing in noninvasive prenatal testing.

The court added that the gender-testing component in the IONA test and Ariosa's Harmony test infringed on another patent.

These patents are licensed by Illumina or its wholly owned subsidiary Verinata Health Inc.

Illumina, which earlier filed multiple lawsuits against Premaitha, said it intends to seek all available remedies, including damages, injunctive relief and attorney fees.

Ariosa Diagnostics Inc. is an indirect subsidiary of Swiss drugmaker Roche Holding AG.